Skip to main content
Log in

Long-term haloperidol-treatment of mice: A change in β-adrenergic receptor responsiveness

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Mice administered haloperidol 3 mg/kg/day in their drinking water for 21 days were tested for their locomotor responsiveness to saline or acid vehicle,dl-, l- ord-propranolol, metoprolol, butoxamine or practolol. Haloperidol-treated animals administered saline or acid-vehicle were, in five of six experiments, more active than animals withdrawn from vehicletreatment. Haloperidol- and vehicle-treated animals responded differently to the non-selectiveβ-adrenoreceptor antagonists (dl-propranolol andl-propranolol) and selectiveβ 1-adrenoreceptor antagonists (practolol and metoprolol), but not to a selectiveβ 2-adrenoreceptor antagonist (butoxamine). Withdl-propranolol (4 mg/kg) the locomotor activity of halo-peridol-treated animals was significantly (0.01<P<0.02) greater than that of the vehicle-treated animals. Similar effects in the same direction were seen withl-propranolol (1 mg/kg, 0.005<P<0.01), practolol (10 and 100 mg/kg, 0.025<P<0.05 and 0.01<P<0.025 respectively) and metoprolol (8 mg/kg, 0.005<P<0.01). Thed-isomer of propranolol which is about 50 times less active as aβ-adrenoreceptor antagonist than thel-isomer, although having equal membrane stabilizing effects, did not differentially affect haloperidol- or vehicle-treated groups. The results suggest that there has been a change inβ 1-adrenoreceptor responsiveness in animals withdrawn from long-term haloperidol treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alexander, R. W., Davis, J. N., Lefkowitz, R. J. Direct identification and characterization ofβ-adrenergic receptors in rat brain. Nature258, 437–440 (1975).

    PubMed  Google Scholar 

  • Atsmon, A., Blum, L., Steiner, M., Latz, A., Wijsenbeek, H. Further studies with propranolol in psychotic patients. Psychopharmacol.27, 249–254 (1972).

    Google Scholar 

  • Barrett, A. M., Cullum, V. A. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias. Brit. J. Pharmacol.34, 43–55 (1968).

    Google Scholar 

  • Delini-Stula, A., Meier, M. Inhibitory effects of propranolol and oxprenolol on excitation produced by a MAO inhibitor and reserpine in the mouse. Neuropharmacol.15, 383–388 (1976).

    Google Scholar 

  • Dollery, C. T., Lewis, P. J. Central hypotensive effect of propranolol. Postgrad. Med. J.52, 116–120 (1976).

    Google Scholar 

  • Dunlop, D., Shanks, R. G. Selective blockade of adrenoceptive beta-receptors in the heart. Brit. J. Pharmacol.32, 201–218 (1968).

    Google Scholar 

  • Dunstan, R., Jackson, D. M. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol. Psychopharmacol.48, 105–114 (1976).

    Google Scholar 

  • Dunstan, R., Jackson, D. M. The effect of apomorphine and clonidine on locomotor activity in mice after long-term treatment with haloperidol. Clin. & Exp. Pharmacol. Physiol.4, 131–141 (1977 a).

    Google Scholar 

  • Dunstan, R., Jackson, D. M. The demonstration of a change in responsiveness of mice to physostigmine after withdrawal from long-term haloperidol pretreatment. J. Neural Transm.40, 181–189 (1977 b).

    PubMed  Google Scholar 

  • Engel, J., Liljeqvist, S., Johannessen, K. Behavioural effects of long-term treatment with antipsychotic drugs. In: Antipsychotic Drugs, Pharmaco-dynamics and Pharmacokinetics (Zotterman, Y., Uvnäs, B., Sedvall, G., eds.), pp. 63–71. New York: Pergamon Press. 1976.

    Google Scholar 

  • Estler, C.-J., Ammon, H. P. T. Absence of central nervous system effects of practolol [ici 50, 172; 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide], a new adrenergicβ-receptor blocking drug. J. Pharm. Pharmacol.21, 554–555 (1969).

    PubMed  Google Scholar 

  • Estler, C.-J., Amman, H. P. T. Modification by two beta-adrenergic blocking drugs of the effects of methamphetamine on behaviour and brain metabolism of mice. J. Neurochem.18, 777–779 (1971).

    PubMed  Google Scholar 

  • Fitzgerald, J. D. Perspectives in adrenergic beta-receptor blockade. Clin. Pharmacol. and Ther.10, 292–297 (1969).

    Google Scholar 

  • Greenblatt, D. J., Shader, R. I. On the psychopharmacology of beta-adrenergic blockade. Current Ther. Res.14, 615–625 (1972).

    Google Scholar 

  • Herman, Z. S. Influence of some psychotropic and adrenergic blocking agents upon amphetamine stereotyped behaviour in white rats. Psycho-pharmacologia (Berl.)11, 136–142 (1967).

    Google Scholar 

  • Jackson, D. M., Dunstan, R., Bracs, P. U. Pharmacological models in tardive dyskinesia: a role for dopamine and noradrenaline. In: Symposium on Drugs and Society (Johnson, G. F. S., ed.), pp. 13–21. Sydney: Ciba-Geigy. 1976.

    Google Scholar 

  • Leszkovszky, G., Tardos, L. Some effects of propranolol on the central nervous system. J. Pharm. Pharmacol.17, 518–520 (1965).

    PubMed  Google Scholar 

  • Mantegazza, P., Naimzada, K. M., Riva, M. Effects of propranolol on some activities of amphetamine. Eur. J. Pharmacol.4, 25–30 (1968).

    PubMed  Google Scholar 

  • Melamed, E., Lahav, M., Atlas, D. Direct localization ofβ-adrenoceptor sites in rat cerebellum by a new fluorescent analogue of propranolol. Nature261, 420–422 (1976).

    PubMed  Google Scholar 

  • Scales, B., Cosgrove, M. B. The metabolism and distribution of the selective adrenergic beta blocking agent, practolol. J. Pharmacol. exp. Ther.175, 338–347 (1970).

    PubMed  Google Scholar 

  • Shah, U. H., Jindal, M. N., Patel, V. K., Kelbar, V. U. Central actions of someβ-adrenoceptor blocking agents. Arzneim.-Forsch.24, 1581–1584 (1974).

    Google Scholar 

  • Shanks, R. G. The peripheral vascular effects of propranolol and related compounds. Brit. J. Pharmacol. Chemother.29, 204–217 (1967).

    Google Scholar 

  • Shanks, R. G. The properties of beta-adrenoceptor antagonists. Postgrad. Med. J.52, suppl. 4, 14–20 (1976).

    Google Scholar 

  • Svensson, T. H., Thieme, G. An investigation of a new instrument to measure motor activity of small animals. Psychopharmacologia (Berl.)14, 157–163 (1969).

    Google Scholar 

  • Tarsy, D., Baldessarini, R. J. Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacol.13, 927–940 (1974).

    Google Scholar 

  • Wasserman, M. A., Levy, B. Selective beta adrenergic receptor antagonism in the anaesthetized dog. J. Pharmacol. exp. Ther.188, 357–367 (1974).

    PubMed  Google Scholar 

  • Āblad, B., Borg, K.-O., Carlsson, E., Johnsson, G., Malmfors, T., Regårdh, C.-G. Animal and human pharmacological studies on metoprolol-a new selective adrenergicβ 1-receptor antagonist. Acta pharmacol. et toxicol.36, 1–144 (1975).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunstan, R., Jackson, D.M. Long-term haloperidol-treatment of mice: A change in β-adrenergic receptor responsiveness. J. Neural Transmission 44, 187–195 (1979). https://doi.org/10.1007/BF01253062

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01253062

Keywords

Navigation